Intrauterine Fetal Death Management
On this page
Direct answer
Intrauterine foetal death — absence of cardiac activity and foetal movements confirmed on ultrasound, ideally reviewed on a second scan — is managed by confirming the diagnosis, investigating the cause, and delivering safely: expectant management is reasonable briefly (about 80 per cent of women labour within 2-3 weeks), but retention beyond roughly four weeks risks disseminated intravascular coagulation from thromboplastin release. Induction is the norm: mifepristone 200 mg orally 36-48 hours before misoprostol — about 200 micrograms vaginally 6-hourly before 28 weeks, 25-50 micrograms 4-6 hourly later. Equal weight goes to grief care, lactation suppression with cabergoline, and a structured work-up: foetal autopsy, placental histology, and maternal investigations.
What you must remember
- Definitions: RCOG defines stillbirth at 24+0 weeks and beyond, ACOG at 20 weeks; Indian registration convention uses 28 weeks or 1000 g — the exam should state which definition it is using.
- Diagnosis: absent cardiac activity on real-time ultrasound, absent foetal movements, and later Spalding's sign (overlapping skull bones) and softening; a repeat scan by a second operator confirms before counselling proceeds.
- Induction regimens: mifepristone 200 mg PO, then 36-48 hours later misoprostol — 200 micrograms vaginally 6-hourly before 28 weeks; 25-50 micrograms 4-6 hourly after (the term myometrium is prostaglandin-sensitive); oxytocin may follow.
- DIC clock: with a macerated foetus retained beyond about 4 weeks, thromboplastin release consumes clotting factors — check platelets, fibrinogen, and prothrombin time before induction in late-presenting cases.
- Cause buckets: unexplained in about a quarter; foetal (anomaly, infection); placental (abruption, vasa praevia, cord accident); maternal (diabetes, pre-eclampsia, malaria and dengue in India, antiphospholipid syndrome, thyroid disease, rhesus disease).
- Work-up: foetal autopsy, placental histology, karyotype where feasible; maternal — Kleihauer, thyroid, HbA1c, antiphospholipid antibodies, infection screen (syphilis, parvovirus, malaria in India), thrombophilia in selected cases.
- Lactation suppression: a single 1 mg dose of cabergoline, or bromocriptine; avoid oestrogen preparations (thrombosis risk).
- The next pregnancy: targeted care — aspirin or low-molecular-weight heparin in antiphospholipid syndrome, glycemic control, and earlier scans for growth.
The pathway after the scan goes silent
The consultant re-scans: no cardiac activity, no movements, skull bones overlapping. Breaking the news happens once, properly — a senior, a private room, both partners, plain words, silence allowed. Confirmation by a second scan is arranged the same day. Then the decisions: timing of delivery (immediate induction versus a day or two for the family to absorb), mode (induction almost always — caesarean for the mother's benefit alone), and place (the labour ward, not a theatre corridor). Mifepristone 200 mg is given, and 36-48 hours later misoprostol; labour in a late IUFD is medically identical to any induction but emotionally inverted, so analgesia is offered early and generously. At birth, the baby is handled with the same dignity as a live birth: seen and held if the parents choose, named, photographed, a memory box; the placenta goes to histology fresh. On the ward, cabergoline suppresses lactation. The follow-up visit at 4-6 weeks returns results, completes the remaining tests, answers the "why" as honestly as the work-up allows, and plans the next pregnancy — for most women, the only question that matters by then.
The Indian dimensions
India's stillbirth numbers remain among the world's highest — the India Newborn Action Plan targets a single-digit rate by 2030 — and the typical Indian IUFD differs from the textbook Western one: malaria, dengue and severe anaemia sit in the cause list alongside diabetes and abruption, many deaths occur at home and arrive already macerated, and the DIC clock has often been ticking for weeks. Grief in the Indian ward has its own texture: the family may shield the mother from the news, naming and seeing the baby may be constrained by custom, and the pressure to conceive again can be immediate — all of which the counsellor must navigate. Mifepristone-misoprostol is the workhorse regimen in government hospitals (both drugs are cheap and on essential lists), while autopsy rates remain low because of cost and consent barriers, leaving "unexplained" categories inflated. The viva: the DIC risk window, the mifepristone interval, and cabergoline for lactation suppression.
Frequently asked questions
How is intrauterine foetal death confirmed?
Absent cardiac activity and movements on ultrasound, reviewed on a repeat scan; Spalding's sign of overlapping skull bones supports maceration.
What is the risk of the expectant approach beyond a few weeks?
Disseminated intravascular coagulation from absorbed thromboplastin (classically after about 4 weeks), plus sepsis and psychological harm — hence planned delivery.
What is the standard induction regimen after IUFD?
Mifepristone 200 mg orally followed 36-48 hours later by misoprostol — around 200 micrograms vaginally 6-hourly before 28 weeks, and 25-50 micrograms 4-6 hourly at later gestations.
Which investigations form the core stillbirth work-up?
Foetal autopsy and placental histology, karyotype where possible; maternal Kleihauer, thyroid, HbA1c, antiphospholipid antibodies, and infection screening including syphilis and, in India, malaria.
How is lactation suppressed after a stillbirth?
A single 1 mg dose of cabergoline (or bromocriptine), with firm support and ice — oestrogen preparations are avoided because of thromboembolic risk.